Bioclinica Wins Clinical Informatics News Best Practices Award for ‘Transformational Medical Imaging in Clinical Trials: SMART Submit’
PRINCETON, N.J. (PRWEB) March 07, 2018 -- Bioclinica®, the world-leading provider of scientific- and technology-enabled solutions for clinical research, is pleased to announce its cloud-based research image management technology, ‘SMART Submit,’ was recognized with a Clinical Informatics News Best Practices Award. The awards program seeks to recognize outstanding examples of applied strategic innovation that improve the clinical trial process. Bioclinica received the award for its innovative, patent-pending technology in the Patient Data Management category at the 2018 SCOPE Summit for Clinical Ops Executives in Orlando, Florida on February 14.
Bioclinica President and CEO David Herron said, “This transformational technology makes the medical image submission process easier, faster and cleaner for clinical research sites anywhere around the globe.” SMART Submit allows high quality images to be sent from research sites direct to the image readers in a matter of minutes. “With such speed, global scale, and accuracy in the imaging management process ─ and with higher quality data and faster data collection ─ sponsors and CROs can more fully recognize the value of scientific insights made possible through medical imaging.”
Allison Proffitt, Clinical Informatics News’ Editorial Director stated, “Our goal each year is to recognize the projects that raise the bar on innovation in clinical trials. This year’s competitive field of entries further proves the dedication of the clinical trials community and industry to improving the clinical trials process for both patients and researchers.”
The technology, acquired and successfully integrated by Bioclinica in 2017, is the backbone of Bioclinica SMART, a best-in-class medical imaging platform for collecting, screening, sanitizing, storing and sending HIPAAcompliant image data in clinical trials. The secure, cloud-based SMART Submit has data centers for global coverage anywhere clinical trials and postmarket surveillance projects are performed so that upload and download speeds are maximized for the local region.
Proprietary algorithms that can be fine-tuned to the trial are used to screen image data before submission, greatly reducing immaterial queries and other issues that unnecessarily burden research sites. “We’re seeing rapid adoption in both pharma and medical device trials,” said Dan Gebow, PhD, Vice President of Imaging Technologies at Bioclinica. “Research sites are thrilled because they’re able to screen medical images for accuracy and integrity prior to upload, thereby preventing queries that used to take them hours to resolve. Sponsors and CROs love it because they get cleaner data faster ̶ and happier, more productive sites.”
Powered by artificial intelligence and machine-learning technologies, over 1,500 screening and de-identification rules are used to detect image issues and automatically de-identify any standard image type. An online hosting environment provides clients with real-time access to imaging data complete with audit trail transparency.
Moreover, SMART Submit removes the variability of improper image de-identification and mislabeling to ensure accuracy, conformance, and efficiency of image analysis. All images are processed to meet DICOM conformance standards and to satisfy health-authority, security, and privacy regulations worldwide. To ensure traceability, unalterable and searchable audit trails record the data stream of all events.
Herron said, “We’re honored to receive this distinguished award; however, what’s truly gratifying is the meaningful value creation in giving sponsors, CROs and research sites advanced image transfer and workflow capability.”
About Bioclinica
Bioclinica is a global life sciences solution provider that utilizes science and technology to bring clarity to clinical trials – helping companies to develop new life-improving therapies more efficiently and safely. Successful clinical trials require the ability to see key details and uncover hidden insights, and Bioclinica’s hundreds of experienced scientific, medical, and domain experts bring unmatched insight across the development lifecycle, from the initial protocol to post-approval. The company’s cloud-based offerings include medical imaging; cardiac safety; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site payments and forecasting; pharmacovigilance; trial management; and risk-based monitoring solutions. A true multifaceted partner to trial sponsors and Contract Research Organizations (CROs), Bioclinica offers an integrated App xChange partner ecosystem, a global network of research sites, patient recruitment services, and post-approval research expertise to provide committed, detail-focused service through all stages of drug development. The company’s thousands of employees serve more than 400 pharmaceutical, biotechnology and device organizations – including all of the top 20 biopharmaceutical companies and leading CROs – through a network of offices in the U.S., Europe, and Asia.
Learn more about Bioclinica, SMART, and other scientific-and technology-enabled offerings at http://www.Bioclinica.com and in the Bioclinica Blog. Follow the latest company news and happenings on LinkedIn and Twitter.
Mary Karpa, Bioclinica, http://www.Bioclinica.com, +1 484-928-6881, [email protected]
Share this article